Study: COPD patients on inhaled drugs more prone to pneumonia

11/26/2008 | Yahoo!

An analysis of 11 studies shows that patients with chronic obstructive pulmonary disease who used inhaled corticosteroids including GlaxoSmithKline's Flovent and AstraZeneca's Pulmicort had a 34% higher risk of developing pneumonia compared with those who did not. Researchers said it remains unclear how the treatments raise the risk and said the finding should not prompt patients to stop taking inhaled steroids.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC